Author/Authors :
Moosavi, Azam Department of Biochemistry - Faculty of Medicine - Alborz University of Medical Sciences, Alborz, Iran , Ardekani, Ali M Department of Medical Biotechnology - National Institute of Genetic Engineering and Biotechnology, Tehran, Iran
Abstract :
Background: β-thalassemia is the most common monogenic disorder in Iran, and one
of the challenges in the screening of the carriers is the coinheritance of α-thalassemia
mutations. In the view of high prevalence of α-thalassemia mutations in many parts
of the country, the aim of this study was to determine the carrier frequency of common
alpha deletions, as a secondary modifier in clinical manifestations of beta thalassemia,
in known beta-thalassemia carriers and some hematology parameter changes.
Methods: The study included families referred from different primary health care centers
with microcytic hypochromic anemia [MCV<80fl; MCH<27 pg] and A2>3.4%]. Genomic
DNA was extracted from peripheral blood leukocytes by salting out method.
For common β-globin gene mutation analysis, amplification refractory mutation system-
polymerase chain reaction (ARMS-PCR) and for rare β-thal alleles, DNA sequencing
were used. Also, for investigation of common α-globin gene cluster deletions
(-α3.7, -α4.2, --MED and -α20.5), multiplex Gap-PCR was performed.
Results: Among 227 β-thalassemia minor individuals studied, α-globin gene deletions
were found in 43 cases: 37 heterozygote -α3.7 (16.3%), 5 homo -α3.7 (2.2%) and 1 --
MED (0.44%). Also, the co-inheritance of α-globin gene deletion and triplication was
not found in the studied individuals.
Conclusion: Although it is highly recommended that physicians and genetic counselors
involved in the screening program of beta-thal major in the country consider this
phenomenon because of high prevalence of this coinheritance, hematologic indices
changes are very slight.